Tuesday, July 21, 2026
🇺🇸 FDA

biotech · PTSD - Post Traumatic Stress Disorder · P1b: Advanced Solid Tumors · CMPX

Compass Therapeutics

Compass Therapeutics patent portfolio — 43 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
80 Guest Street, Suite 601, Boston, MA 02135, US HQ
2014 Founded
54 Employees
Public company Type
CMPX · NYSE Ticker
Company details
Status
Public
HQ
80 Guest Street, Suite 601, Boston, MA 02135, US
Founded
2014
Employees
54
Programs
0
Drugs
2
Patents
43
Official website ↗ Drug pipeline Patents News & analysis
Intelligence · Patents

Compass Therapeutics patents

43 pharmaceutical patents indexed for Compass Therapeutics. 0 expire within 24 months.

Compass Therapeutics has 43 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

43 patents

Patent portfolio

  1. US 11865179

    Progesterone formulations having a desirable PK profile

    Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11793819

    Natural combination hormone replacement formulations and therapies

    Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11529360

    Natural combination hormone replacement formulations and therapies

    Expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11497709

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Expires Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11351182

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11304959

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11266661

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11246875

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Expires Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11241445

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Expires Mon Feb 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11166963

    Natural combination hormone replacement formulations and therapies

    Expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11123283

    Soluble estradiol capsule for vaginal insertion

    Expires Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11116717

    Soluble estradiol capsule for vaginal insertion

    Expires Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11110099

    Natural combination hormone replacement formulations and therapies

    Expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11103513

    Natural combination hormone replacement formulations and therapies

    Expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11065197

    Soluble estradiol capsule for vaginal insertion

    Expires Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11033626

    Progesterone formulations having a desirable pk profile

    Expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10888516

    Soluble estradiol capsule for vaginal insertion

    Expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10835487

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10806740

    Natural combination hormone replacement formulations and therapies

    Expires Mon Oct 15 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10806697

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Expires Mon Oct 15 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 10675288

    Natural combination hormone replacement formulations and therapies

    Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 10668082

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 10639375

    Progesterone formulations

    Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 10568891

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 10537581

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Expires Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 10471072

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Expires Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 10398708

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 10258630

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 10206932

    Natural combination hormone replacement formulations and therapies

    Expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 10052386

    Progesterone formulations

    Expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9301920

    Natural combination hormone replacement formulations and therapies

    Expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9289382

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Expires Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9180091

    Soluble estradiol capsule for vaginal insertion

    Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9114145

    Natural combination hormone replacement formulations and therapies

    Expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9114146

    Natural combination hormone replacement formulations and therapies

    Expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9006222

    Natural combination hormone replacement formulations and therapies

    Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8993548

    Natural combination hormone replacement formulations and therapies

    Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8993549

    Natural combination hormone replacement formulations and therapies

    Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8987237

    Natural combination hormone replacement formulations and therapies

    Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8933059

    Natural combination hormone replacement formulations and therapies

    Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8846648

    Natural combination hormone replacement formulations and therapies

    Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8846649

    Natural combination hormone replacement formulations and therapies

    Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8633178

    Natural combination hormone replacement formulations and therapies

    Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Compass Therapeutics have?

43 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Compass Therapeutics patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.